Eurocine Vaccines´ Chlamydia vaccine candidate elicits both antibody and T cell responses
In the latest preclinical study, it was shown that intramuscular immunization with the Chlamydia vaccine candidate elicits an excellent T cell response, in addition to…
Correction: Eurocine Vaccines discloses interim report for July – September 2021
Correction: In the interim report for July – September 2021, information whether the report has been reviewed by the company’s auditor was not included. The…
Eurocine Vaccines discloses interim report for July – September 2021
Eurocine Vaccines AB hereby discloses the interim report for July – September 2021. Below is a summary of the report. The full report is available…
Disclosure notice in Eurocine Vaccines
Eurocine Vaccines hereby announces that Flerie Invest AB has acquired shares in the company and holds above 10 % of the shares in the company.…
Eurocine Vaccines discloses year-end report for the fiscal year 2020/2021
Eurocine Vaccines AB (“Eurocine Vaccines”) hereby discloses the year-end report for the fiscal year 2020/2021. Below is a summary of the report. The full report…
Eurocine Vaccines extends its product portfolio with a diagnostic test of chlamydia through a widened agreement with Spixia Biotechnology
Eurocine Vaccines AB has decided to evaluate a diagnostic test of chlamydia antibodies in blood as an extension of its portfolio and has widened the…
Eurocine Vaccines presented at BOS Virtual 2021
On 1 July 2021, CEO Hans Arwidsson gave a presentation at BOS, Biotech Outsourcing Strategies, Virtual 2021, which is an event arranged by Bio2Business Ltd.,…
Interviews with CEO Hans Arwidsson
Eurocine Vaccines AB has published two interviews with CEO Hans Arwidsson in connection with the ongoing preferential issue of units. The interviews, which have partly…
Eurocine Vaccines prepares to evaluate two more vaccine candidates
As part of its portfolio strategy, Eurocine Vaccines is actively searching for new vaccine candidates to expand the portfolio. Of the currently ongoing discussions with…
Eurocine Vaccines presentation från Aktieportföljen Live
Eurocine Vaccines presenterade verksamheten, framtidsplaner, vaccinmarknaden och samarbeten, bland annat relaterat till en vaccinkandidat mot klamydia, på Aktieportföljen Live den 26 maj 2021.Read More